Study guide
Miscarriage and ectopic pregnancy
AMC CAT MCQ Examination AMC Part 1
Track your progress as you read
Finished sections get a check mark.
1 Acute Coronary Syndromes & ECG Localization
ACS recognition and ECG localisation Reperfusion and infarction complications
2 Heart Failure, Cardiogenic Shock & Cardiac Arrhythmias
Heart failure assessment and treatment Arrhythmias and conduction emergencies
3 Systemic Hypertension & Peripheral Vascular Disease
Blood pressure and cardiovascular risk Secondary hypertension and arterial disease
4 Valvular Heart Disease, Infective Endocarditis & Pericarditis
Aortic and mitral valve disease Endocarditis and pericardial emergencies
5 Asthma & COPD Acute Flares and Maintenance
Asthma and COPD diagnosis and maintenance Acute asthma and COPD exacerbations
6 Pneumonia, pleural disease and respiratory failure
Pneumonia and infected pleural collections Pulmonary embolism, effusions and pneumothorax Respiratory failure, ARDS and sepsis
7 GI bleeding, bowel inflammation and malabsorption
GI bleeding assessment and resuscitation Varices, ulcers, reflux and lower GI bleeding IBD patterns and severe colitis assessment IBD treatment, coeliac disease and IBS
8 Chronic Liver Disease, Cirrhosis Complications & Acute Hepatitis
Cirrhosis diagnosis and prognosis Decompensation, viral hepatitis and surveillance
9 Diabetes, thyroid and adrenal disease
Diabetes diagnosis and ongoing care DKA, HHS and complication monitoring Thyroid disease assessment Thyroid emergencies and adrenal disease
10 Acute Kidney Injury, Chronic Kidney Disease & Fluid/Electrolyte Emergencies
AKI and chronic kidney disease Potassium and sodium emergencies
11 Anaemias, Inflammatory Arthropathies & Geriatric Comprehensive Assessment
Anaemia, bruising and blood disorders Arthritis, autoimmune disease and geriatric care
12 Evaluation of the Acute Abdomen, Peritonitis & Appendicitis
Abdominal pain, peritonitis and resuscitation Appendicitis diagnosis and treatment Perforation and mesenteric ischaemia
13 Small and Large Bowel Obstruction & Colorectal Surgical Pathology
Small bowel obstruction Colonic obstruction, volvulus and cancer recognition Colorectal care, diverticulitis and anorectal symptoms
14 Gallbladder Disease, Biliary Tract Infections & Acute Pancreatitis
Gallstones and biliary obstruction Cholangitis and pancreatitis diagnosis Pancreatitis severity and treatment
15 Advanced Trauma Life Support, Primary Survey & Life-Threatening Thoracic Injuries
Trauma primary survey and adjuncts Chest trauma and immediate threats
16 Traumatic Brain Injury, Intracranial Haemorrhage & Spinal Cord Clearance
Head injury, imaging and haemorrhage Herniation and spinal cord injury
17 Major Fractures, Joint Dislocations & Acute Compartment Syndrome
Fracture assessment and open injuries Compartment syndrome, dislocations and pelvic injury
18 Thermal Burns, Haemorrhagic Shock Resuscitation & Surgical Wound Care
Burn assessment and fluid resuscitation Bleeding shock, wound care and tetanus
19 Aortic Aneurysms & Acute Arterial Limb Ischaemia
Aneurysm recognition and planned care Ruptured aneurysm and acute limb ischaemia
20 Urological Emergencies, Testicular Torsion & Haematuria Investigation
Retention, stones and obstructed infection Scrotal pain and haematuria
21 Preoperative Risk Stratification & Postoperative Surgical Complications
Preoperative assessment and medicines Postoperative complications and prevention
22 Early Pregnancy Bleeding, Ectopic Pregnancy & Antenatal Screening
Miscarriage and ectopic pregnancy Antenatal screening and early-pregnancy comparisons
23 Hypertensive Disorders of Pregnancy & Medical Complications in Pregnancy
Pregnancy hypertension and preeclampsia Eclampsia, HELLP and antepartum bleeding
24 Intrapartum Monitoring, Postpartum Haemorrhage & Obstetric Emergencies
Labour physiology and CTG assessment CTG response and postpartum haemorrhage Obstetric emergencies and preterm birth
25 Abnormal Uterine Bleeding, Pelvic Pain & Endometriosis
Abnormal bleeding and structural causes Endometrial sampling and endometriosis PCOS diagnosis and long-term care
26 Contraception, Emergency Contraception & Pregnancy Termination
Contraceptive choice and missed pills Emergency contraception and abortion
27 Australian Cervical Screening Program & Gynaecological Malignancies
Cervical screening and cervical cancer Endometrial and ovarian cancer
28 Neonatal Resuscitation, Congenital Conditions & Neonatal Jaundice
Newborn resuscitation, Apgar and cyanosis Neonatal jaundice assessment Jaundice treatment and congenital screening
29 Developmental Milestones, Growth Charts & Failure to Thrive
Developmental milestones Regression, autism and support Faltering growth and developmental comparisons
30 The Limping Child, Septic Arthritis vs Transient Synovitis & Paediatric Hip Conditions
Limp assessment and septic-joint risk Joint-infection management and Perthes disease SUFE and paediatric hip comparisons
31 Croup, Bronchiolitis, Paediatric Asthma & Anaphylaxis
Croup Bronchiolitis Paediatric asthma Paediatric anaphylaxis
32 Evaluation of the Febrile Child, Sepsis & Meningococcal Disease
Febrile neonates and young infants Meningococcal disease and paediatric sepsis Bacterial meningitis and CSF interpretation Kawasaki disease and follow-up
33 Paediatric Surgical Abdomen, Dehydration & Child Protection / Non-Accidental Injury
Pyloric stenosis Intussusception and dehydration Child protection and injury assessment
34 The Mental State Examination & Suicide Risk Stratification
Mental state examination and psychotic symptoms Suicide formulation and mental health law
35 Major Depressive Disorder, Bipolar Affective Disorder & Mood Stabilisers
Depression assessment and treatment Serotonin toxicity and bipolar presentations Mood stabilisers and ECT
36 Generalised Anxiety, Panic Disorder, PTSD & Obsessive-Compulsive Disorder
Anxiety, panic and agoraphobia OCD and trauma-related disorders
37 Schizophrenia, Acute Psychosis & Antipsychotic Management
Psychosis assessment and antipsychotics Clozapine and severe adverse effects
38 Substance Use Disorders & Acute Withdrawal Syndromes
Substance disorders and alcohol withdrawal Wernicke disease, opioids and stimulants
39 Delirium vs Dementia, Perinatal Mood Disorders & Paediatric Psychiatry
Delirium and dementia assessment Cognitive behaviour, perinatal and childhood psychiatry
40 Medicare, PBS, AHPRA & Good Medical Practice Framework
Australian health services and Medicare PBS access and professional registration Professional boundaries and notifications
41 Informed Consent (Rogers v Whitaker), Mental Capacity & Involuntary Treatment
Consent, material risks and young people Capacity, refusal and substitute decisions
42 Patient Privacy, Confidentiality Exceptions & Mandatory Notifications
Privacy, disclosure and child reporting Driving fitness and threat disclosure
43 First Nations health and preventive care
First Nations health, determinants and cultural safety Community care, Item 715 and CTG medicines Immunisation and cancer screening entry points Screening pathways and primary CVD prevention
44 Epidemiological Metrics, Clinical Study Designs & Notifiable Communicable Diseases
Epidemiology, calculations, bias and surveillance
45 Neurological presentations
Stroke, TIA and focal weakness Headache, facial pain and vertigo Seizures, collapse and altered consciousness Numbness, movement disorders and generalised weakness
46 Musculoskeletal pain
Back, neck, bone and soft tissue pain
47 Eye presentations
Altered vision and retinal disease Red eye, ocular injury and discharge
48 Ear, nose, throat and oral health
Ear pain, hearing loss and tinnitus Nasal problems, neck lumps, hoarseness and dysphagia Toothache, mouth symptoms, dry mouth and halitosis
49 Skin, hair and nails
Rash, itch, infection and skin ulcers Skin lesions, hair loss and nail abnormalities
50 Breast health and feeding
Breast lumps, discharge and breastfeeding problems
51 Sexual and reproductive presentations
Genital symptoms, discharge and pelvic infection Menopause, prolapse and urinary symptoms Infertility and sexual dysfunction
52 Palliative care and carers
The dying patient, symptoms and carers
53 Eating disorders and personality care
Eating disorders, obesity and weight change Personality difficulties, self-harm and complex care
54 Sleep presentations
Insomnia, snoring and daytime sleepiness
55 Poisoning, resuscitation and environmental emergencies
Poisoning, toxidromes and antidote decisions Cardiopulmonary arrest, choking and emergency help Bites, stings, heat, cold and drowning
56 Communication, rights and professional practice
Communication, handover, errors and complaints Healthcare rights, inclusive care and equitable access Certificates, deaths, CPD and supervision Telehealth, images, prescribing and doctors' health
57 Genetics, research and donation
Genetic testing, research and organ donation
58 Travel, fever and outbreaks
Fever, travellers and outbreak response
Miscarriage and ectopic pregnancy
Key Takeaways Explain This Topic AI
Pregnancy of unknown location is an ultrasound classification, not a low-hCG diagnosis.
A single hCG value cannot prove ectopic pregnancy.
Haemodynamic instability with suspected ectopic rupture requires urgent surgical care.
Last updated: October 2026
Early Pregnancy Bleeding, Ectopic Pregnancy & Antenatal Screening
Vaginal bleeding in the first trimester occurs in approximately 20% to 25% of confirmed pregnancies and represents one of the most common acute presentations in Australian primary care and emergency departments. The primary clinical objectives are distinguishing viable intrauterine pregnancies from non-viable pregnancies (miscarriage) or life-threatening extrauterine gestations (ectopic pregnancy), assessing maternal haemodynamic stability, and implementing appropriate Rh(D) isoimmunisation prophylaxis.
Clinical Classification of Miscarriage
Miscarriage is defined as the spontaneous loss of a pregnancy before 20 weeks of gestation. Clinical classification relies on symptoms (bleeding, pain), speculum examination of the external and internal cervical os, and transvaginal ultrasonography (TVS):
Threatened Miscarriage : Characterized by light vaginal bleeding and mild suprapubic cramping in the presence of a closed internal cervical os. Transvaginal ultrasound confirms a viable intrauterine pregnancy with documented fetal cardiac activity. The vast majority of cases resolve spontaneously with a favorable outcome; management is expectant with reassurance and repeat clinical review.
Inevitable Miscarriage : Characterized by open internal cervical os with active vaginal bleeding and progressive lower abdominal cramping. Spontaneous expulsion of products of conception (POC) has not yet occurred, but pregnancy loss is unavoidable. Ultrasound confirms non-viability or detachment of the gestational sac.
Incomplete miscarriage: Some tissue has passed with ongoing bleeding/cramps and possible retained products. Interpret ultrasound with symptoms and prior confirmed pregnancy; an endometrial thickness alone does not mandate evacuation.
Complete miscarriage: Symptoms settle after tissue passage in a previously confirmed IUP. If no IUP was previously confirmed, an empty uterus can still be PUL and requires follow-up; do not simply reassure from a thin stripe.
Missed (Silent or Delayed) Miscarriage : The embryo or fetus has died or failed to develop (anembryonic pregnancy / blighted ovum), but the non-viable gestational tissue is retained in utero. The internal cervical os remains closed, and the patient may be asymptomatic or notice a gradual regression of early pregnancy symptoms. Definitive ultrasound criteria for missed miscarriage include:
Crown-rump length (CRL) ≥ 7 mm \ge 7\text{ mm} ≥ 7 mm with no visible fetal cardiac activity.
Mean gestational sac diameter (MSD) ≥ 25 mm \ge 25\text{ mm} ≥ 25 mm without an identifiable embryo.
Absence of an embryo with a heartbeat ≥ 14 days \ge 14\text{ days} ≥ 14 days after a scan showing an empty gestational sac without a yolk sac (or ≥ 11 days \ge 11\text{ days} ≥ 11 days after a scan showing a gestational sac with a yolk sac).
Septic Miscarriage : Any miscarriage subtype complicated by ascending intrauterine infection. Manifests with maternal fever, rigors, tachycardia, offensive or purulent vaginal discharge, exquisite uterine tenderness, and cervical motion tenderness. Requires immediate hospital admission, high-dose intravenous broad-spectrum antibiotics (ampicillin, gentamicin, and metronidazole), aggressive fluid resuscitation, and emergent surgical evacuation.
Management Strategies for Miscarriage
Expectant Management : First-line for stable, afebrile patients with incomplete or missed miscarriage < 6 weeks < 6\text{ weeks} < 6 weeks . Success rates range between 70% and 80% over 1 to 2 weeks. Follow-up includes serial clinical review and repeat TVS or urine pregnancy testing at 2 to 3 weeks.
Medical Management : Indicated for women seeking active expulsion without surgical intervention. The recommended regimen is oral or vaginal misoprostol ( 800 mcg 800\text{ mcg} 800 mcg vaginally, or 600 mcg 600\text{ mcg} 600 mcg sublingually). Misoprostol induces myometrial contractions and cervical softening. Adequate analgesia (paracetamol, NSAIDs, or codeine) and antiemetics should be co-prescribed. If complete expulsion is not achieved, a second dose may be administered at 24 to 48 hours.
Surgical Management : Suction evacuation / curettage under general or local anaesthesia is indicated for haemodynamic instability, active uncontrolled uterine haemorrhage, clinical evidence of infection (septic miscarriage), suspected gestational trophoblastic disease, or patient preference. Preoperative cervical priming with misoprostol ( 400 mcg 400\text{ mcg} 400 mcg ) is often employed.
RhD prophylaxis: For a non-sensitised RhD-negative patient, the 2024 National Blood Authority guideline recommends 250 IU for first-12-week miscarriage, ectopic pregnancy, molar pregnancy or chorionic-villus sampling. Light threatened bleeding does not routinely require anti-D; repeated/heavy bleeding, pain or trauma may justify it. Abortion has separate newer guidance: RANZCOG 2025 does not require routine RhD testing for medical or surgical abortion up to 10 weeks. Later events require the gestation-specific guideline; after 12 weeks the usual dose is 625 IU.
Ectopic Pregnancy
Ectopic pregnancy occurs when a blastocyst implants outside the endometrial cavity, with approximately 95% situated in the fallopian tube (ampullary 70%, isthmic 12%, fimbrial 11%, and interstitial/cornual 2% to 3%). Interstitial ectopic gestations implant in the myometrial segment of the fallopian tube and can expand unnoticed until 12 to 16 weeks, where catastrophic rupture leads to massive intraperitoneal exsanguination.
- Risk Factors
- Prior ectopic pregnancy (highest relative risk, ~10-fold increase)
- History of pelvic inflammatory disease (salpingitis) or tubal infection (Chlamydia trachomatis)
- Previous tubal surgery (reconstructive surgery or sterilization reversal)
- Assisted reproductive technologies (in vitro fertilisation - IVF)
Conception with an intrauterine device (IUD) in situ (the absolute pregnancy rate is low, but if conception occurs, up to 50% are ectopic)
- Endometriosis and maternal cigarette smoking
- Clinical Presentation and Diagnosis
The classic triad of ectopic pregnancy comprises amenorrhoea , unilateral lower abdominal or pelvic pain , and abnormal vaginal bleeding (characteristically dark brown "prune juice" spotting). Ruptured ectopic pregnancy presents with acute haemoperitoneum: sudden severe peritoneal pain, diaphoresis, syncope, peritonism with rebound tenderness and cervical motion tenderness, subdiaphragmatic irritation producing referred unilateral shoulder tip pain (Kehr sign), and hypovolaemic shock.
PUL: An empty uterus with positive hCG does not diagnose ectopic pregnancy, including above a traditional discriminatory range. Review symptoms, serial hCG and expert ultrasound; follow until location/outcome is established. Do not give methotrexate solely because a threshold was crossed.
Definition: PUL means positive hCG with neither an intrauterine nor extrauterine pregnancy visible; it is not restricted to hCG below 1,500. Unstable pain, syncope or heavy bleeding requires immediate reassessment.
hCG trends: A viable pregnancy may rise more slowly than a memorised doubling rule. A falling or suboptimal rise does not localise the pregnancy. Follow serial hCG and ultrasound until location/outcome is established, with immediate return for pain, syncope or heavy bleeding.
Non-viable intrauterine pregnancy / resolving miscarriage: serum β \beta β -hCG drops by > 50 % > 50\% > 50% .
Falling or plateauing hCG can occur in different outcomes and does not localise the pregnancy. Continue follow-up and safety-net for rupture symptoms.
Transvaginal Ultrasound Findings :
Empty uterine cavity with thickened decidualised endometrium
Pseudo-gestational sac: a central, homogeneous intrauterine fluid collection lacking the double decidual sac sign
- Inhomogeneous, complex adnexal mass separate from the ovary
- "Tubal ring sign" (bag of pearls): echogenic ring surrounding an extrauterine gestational sac
- Free fluid in the pouch of Douglas or Morison pouch (echogenic fluid indicates haemoperitoneum)
- Management Modalities
Medical Management (Methotrexate) : Single-dose intramuscular methotrexate ( 50 mg/m 2 50\text{ mg/m}^2 50 mg/m 2 body surface area) is an established alternative to surgery in strictly selected, stable patients. Criteria for medical therapy:
- Haemodynamically stable without severe pain or peritoneal irritation
- Serum β -hCG < 5 , 000 IU/L \beta\text{-hCG} < 5,000\text{ IU/L} β -hCG < 5 , 000 IU/L
- Unruptured ectopic mass < 35 mm < 35\text{ mm} < 35 mm on TVS
- Absence of embryonic cardiac activity on TVS
- Normal baseline full blood count, renal function, and liver enzyme levels
- Reliable patient able to attend outpatient monitoring on day 4 and day 7
Monitoring Protocol : Serum β \beta β -hCG is measured on day 4 and day 7. An initial rise between day 1 and day 4 is normal. A reduction of ≥ 15 % \ge 15\% ≥ 15% between day 4 and day 7 indicates successful response, followed by weekly β \beta β -hCG until < 5 IU/L < 5\text{ IU/L} < 5 IU/L . If < 15 % < 15\% < 15% reduction occurs, a second dose of methotrexate or laparoscopic surgery is required.
Surgical Management (Laparoscopy) :
Laparoscopic salpingectomy is the gold standard in Australia. Preferred in women with haemodynamic instability, ruptured ectopic pregnancy, acute peritoneal irritation, serum β -hCG ≥ 5 , 000 IU/L \beta\text{-hCG} \ge 5,000\text{ IU/L} β -hCG ≥ 5 , 000 IU/L , adnexal mass ≥ 35 mm \ge 35\text{ mm} ≥ 35 mm , or visible fetal cardiac activity.
Laparoscopic salpingostomy (incising the tube and extracting the trophoblast) is reserved for women with a severely damaged or absent contralateral fallopian tube who desire future fertility. Requires postoperative weekly β \beta β -hCG monitoring to exclude persistent trophoblastic tissue (occurs in ~10% of cases).
Primary references (checked 7 October 2026): ADIPS 2025 diagnostic recommendations ; National Blood Authority anti-D guideline .